Literature DB >> 30484403

Activation of AMPK by Medicinal Plants and Natural Products: Its Role in Type 2 Diabetes Mellitus.

Flavio Francini1, Guillermo R Schinella2,3, José-Luis Ríos4.   

Abstract

Type-2 Diabetes (T2D) is a metabolic disease characterized by permanent hyperglycemia, whose development can be prevented or delayed by using therapeutic agents and implementing lifestyle changes. Some therapeutic alternatives include regulation of glycemia through modulation of different mediators and enzymes, such as AMP-activated protein kinase (AMPK), a highly relevant cellular energy sensor for metabolic homeostasis regulation, with particular relevance in the modulation of liver and muscle insulin sensitivity. This makes it a potential therapeutic target for antidiabetic drugs. In fact, some of them are standard drugs used for treatment of T2D, such as biguanides and thiazolidindiones. In this review, we compile the principal natural products that are activators of AMPK and their effect on glucose metabolism, which could make them candidates as future antidiabetic agents. Phenolics such as flavonoids and resveratrol, alkaloids such as berberine, and some saponins are potential natural activators of AMPK with a potential future as antidiabetic drugs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  AMPK; antidiabetic drugs; medicinal plants; natural products; type 2 diabetes mellitus.

Mesh:

Substances:

Year:  2019        PMID: 30484403     DOI: 10.2174/1389557519666181128120726

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  6 in total

1.  Impact of flavonol extracts derived from green tea or targeted flavonols as secondary ingredients on intestinal glucose transport.

Authors:  Yeong-Eun Lee; So-Hee Yoo; Jin-Oh Chung; Chan-Su Rha; Mi-Young Park; Hyun-Jeong Lee; Jeong-Ho Oh; Yong-Deog Hong; Soon-Mi Shim
Journal:  J Food Sci Technol       Date:  2021-05-26       Impact factor: 2.701

2.  Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice.

Authors:  Chian-Jiun Liou; Shu-Ju Wu; Szu-Chuan Shen; Li-Chen Chen; Ya-Ling Chen; Wen-Chung Huang
Journal:  Cell Biosci       Date:  2020-09-29       Impact factor: 7.133

3.  Nicotinamide Riboside Enhances Endothelial Precursor Cell Function to Promote Refractory Wound Healing Through Mediating the Sirt1/AMPK Pathway.

Authors:  Zhen-Hua Wang; Xiao-Gang Bao; Jun-Jie Hu; Si-Bo Shen; Guo-Hua Xu; Ye-Lin Wu
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

4.  HPLC-MS and Network Pharmacology Analysis to Reveal Quality Markers of Huo-Xue-Jiang-Tang Yin, a Chinese Herbal Medicine for Type 2 Diabetes Mellitus.

Authors:  Qiugu Chen; Yuan Zhao; Maosheng Li; Ping Zheng; Shangbin Zhang; Huilin Li; Jianping Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-15       Impact factor: 2.629

Review 5.  A Review on the Antidiabetic Properties of Moringa oleifera Extracts: Focusing on Oxidative Stress and Inflammation as Main Therapeutic Targets.

Authors:  Fikile T Mthiyane; Phiwayinkosi V Dludla; Khanyisani Ziqubu; Sinenhlanhla X H Mthembu; Ndivhuwo Muvhulawa; Nokulunga Hlengwa; Bongani B Nkambule; Sithandiwe E Mazibuko-Mbeje
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

6.  Semantic text mining in early drug discovery for type 2 diabetes.

Authors:  Lena K Hansson; Rasmus Borup Hansen; Sune Pletscher-Frankild; Rudolfs Berzins; Daniel Hvidberg Hansen; Dennis Madsen; Sten B Christensen; Malene Revsbech Christiansen; Ulrika Boulund; Xenia Asbæk Wolf; Sonny Kim Kjærulff; Martijn van de Bunt; Søren Tulin; Thomas Skøt Jensen; Rasmus Wernersson; Jan Nygaard Jensen
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.